SANTA CLARA, Calif. — At a press event, Intel Corp. here disclosed that it is exploring a lab-on-a-chip technology for the medical market.
The so-called Intel BioElectronic Chip is said to enable point-of-care diagnostics and laboratory testing, according to Intel (Santa Clara, Calif.).
''Using a simplified field effect device (FED) modified by biological molecules, electronic signal is facilitated upon detecting specific biomarkers,'' according to Intel. ''The device has the potential of multiplexed detection providing diagnostic profile.''
An official from Intel said the technology is still in the labs. The company has not commercialized the product.
A growing number of chip companies are developing products in the booming medical field, including Microchip, Texas Instruments and others.